Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxapram to hasten emergence from dexmedetomidine-propofol-remifentanil total intravenous anesthesia
ChiCTR-TRC-13003346Phase 4Completed
- Sponsor
- Department of Anesthesiology, Qilu Hospital, Shandong University
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of doxapram in obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Department of Anesthesiology, Qilu Hospital, Shandong University. Primary endpoint: Time to eye opening on verbal command. Started Jun 2013; status: completed.
02
Drugs
doxapram
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ChiCTR-TRC-13003346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003346.